01-12-2023 | Vilanterol | Case report
Cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamide/vilanterol/fluticasone-furoate interaction
Adrenal insufficiency
Published in: Reactions Weekly | Issue 1/2023
Login to get accessExcerpt
Author Information
An event is serious (based on the ICH definition) when the patient outcome is: Drug interaction
-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event